Skip to main content
  • Management
      |Management
    • Compensation
    • Economics
    • Leadership
    • Legal News
    • Mergers & Acquisitions
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Imaging
      |Imaging
    • CT
    • MRI
    • Nuclear Medicine
    • Ultrasound
    • Women's Imaging
    • X-ray
  • Technology
      |Technology
    • Artificial Intelligence
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • PACS
  • Videos
  • Conferences
      |Conferences
    • ACR
    • AHRA
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SCCT
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025
    • Class of 2024

Search form

Home

News You Need to Know Today
Radiologist FDA leader wants gen-AI regulated like human docs | AI for checking AI's work | Radiation could treat Parkinson's
Thursday, October 22, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Radiologist FDA leader believes generative AI should be evaluated like human docs

Rick Abramson, MD, director of the FDA’s Digital Health Center of Excellence, recently spoke during a panel held in Boston by industry lobbying group AdvaMed. 

READ MORE >
FDA U.S. Food and Drug Administration
Share on Twitter Share on Facebook Share on Linkedin

Radiologist FDA leader believes generative AI should be evaluated like human docs

Share on Twitter Share on Facebook Share on Linkedin
FDA U.S. Food and Drug Administration
Rick Abramson, MD, director of the FDA’s Digital Health Center of Excellence, recently spoke during a panel held in Boston by industry lobbying group AdvaMed. 
READ MORE >

Artificial intelligence checks the trustworthiness of breast cancer AI models

University of Pittsburgh experts believe the model could help radiologists identify cases when an AI-generated result may need a second look. 

READ MORE >
breast cancer mammography women's imaging
Share on Twitter Share on Facebook Share on Linkedin

Artificial intelligence checks the trustworthiness of breast cancer AI models

Share on Twitter Share on Facebook Share on Linkedin
breast cancer mammography women's imaging
University of Pittsburgh experts believe the model could help radiologists identify cases when an AI-generated result may need a second look. 
READ MORE >

Body composition changes on CT could signal pancreatic cancer years before diagnosis

PDAC is frequently diagnosed at an advanced stage, and most cases occur in people who do not meet current criteria for high-risk surveillance, which allows the cancer to progress before it is diagnosed. 

READ MORE >
AI helps spot pancreatic cancer over a year before radiologists can
Share on Twitter Share on Facebook Share on Linkedin

Body composition changes on CT could signal pancreatic cancer years before diagnosis

Share on Twitter Share on Facebook Share on Linkedin
AI helps spot pancreatic cancer over a year before radiologists can
PDAC is frequently diagnosed at an advanced stage, and most cases occur in people who do not meet current criteria for high-risk surveillance, which allows the cancer to progress before it is diagnosed. 
READ MORE >

World’s 1st study to test whether low-dose radiation could curb Parkinson’s

While radiation therapy is typically used for cancer—damaging tumor cells and stopping growth—Mayo Clinic scientists hope lowering the dose can curb brain inflammation tied to the disorder. 

READ MORE >
stroke brain dementia alzheimer's puzzle mental health
Share on Twitter Share on Facebook Share on Linkedin

World’s 1st study to test whether low-dose radiation could curb Parkinson’s

Share on Twitter Share on Facebook Share on Linkedin
stroke brain dementia alzheimer's puzzle mental health
While radiation therapy is typically used for cancer—damaging tumor cells and stopping growth—Mayo Clinic scientists hope lowering the dose can curb brain inflammation tied to the disorder. 
READ MORE >

Private equity-backed urology group opens 2 new interventional radiology centers

New Jersey Urology will soon begin providing image guided procedures for enlarged prostates and other clinical concerns across the Garden State. 

READ MORE >
IR Centers
Share on Twitter Share on Facebook Share on Linkedin

Private equity-backed urology group opens 2 new interventional radiology centers

Share on Twitter Share on Facebook Share on Linkedin
IR Centers
New Jersey Urology will soon begin providing image guided procedures for enlarged prostates and other clinical concerns across the Garden State. 
READ MORE >

Nevada hospital launches residency program to address radiologist shortage

A new Las Vegas diagnostic residency program aims to address the state's staffing challenges by training rads locally and encouraging them to stay in Nevada. 

READ MORE >
radiology residents training
Share on Twitter Share on Facebook Share on Linkedin

Nevada hospital launches residency program to address radiologist shortage

Share on Twitter Share on Facebook Share on Linkedin
radiology residents training
A new Las Vegas diagnostic residency program aims to address the state's staffing challenges by training rads locally and encouraging them to stay in Nevada. 
READ MORE >

FDA clears Elucid's new AI-enabled FFR-CT software

According to Elucid, the development of its FFR-IQ software was guided by clinician feedback.

READ MORE >
The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Elucid's FFR-IQ software for the noninvasive estimation of fractional flow reserve from coronary CT angiography (FFR-CT). The artificial intelligence (AI) based technology incorporates coronary anatomy and plaque composition into its estimation of coronary physiology for a more accurate and individualized assessment to aid in treatment decisions.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears Elucid's new AI-enabled FFR-CT software

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Elucid's FFR-IQ software for the noninvasive estimation of fractional flow reserve from coronary CT angiography (FFR-CT). The artificial intelligence (AI) based technology incorporates coronary anatomy and plaque composition into its estimation of coronary physiology for a more accurate and individualized assessment to aid in treatment decisions.
According to Elucid, the development of its FFR-IQ software was guided by clinician feedback.
READ MORE >

In Other News

AI-powered ECG assessments may improve heart transplant rejection warnings

Researchers said they plan on testing the AI model in additional patients at several transplant centers.

READ MORE >
transplant.jpg
Share on Twitter Share on Facebook Share on Linkedin

AI-powered ECG assessments may improve heart transplant rejection warnings

Share on Twitter Share on Facebook Share on Linkedin
transplant.jpg
Researchers said they plan on testing the AI model in additional patients at several transplant centers.
READ MORE >

Incoming ASNC president wants to expand access to cardiac PET

ASNC focuses on selecting the appropriate examination for each patient rather than treating one modality as universally preferable. At the same time, cardiac PET has been linked to key benefits that could improve patient care if only more clinicians could use it. ASNC's next president, Andrew Einstein, MD, PhD, discussed this and more in a new interview.

READ MORE >
Andrew Einstein, MD, PhD, FACC, MASNC, MSCCT, FSCMR, incoming 2027 president of the American Society of Nuclear Cardiology (ASNC), professor of medicine in radiology, and director of nuclear cardiology, cardiac CT and cardiac MRI at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, shares ASNC's goals in 2027. #CVnuc #ThinkPET
Share on Twitter Share on Facebook Share on Linkedin

Incoming ASNC president wants to expand access to cardiac PET

Share on Twitter Share on Facebook Share on Linkedin
Andrew Einstein, MD, PhD, FACC, MASNC, MSCCT, FSCMR, incoming 2027 president of the American Society of Nuclear Cardiology (ASNC), professor of medicine in radiology, and director of nuclear cardiology, cardiac CT and cardiac MRI at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, shares ASNC's goals in 2027. #CVnuc #ThinkPET
ASNC focuses on selecting the appropriate examination for each patient rather than treating one modality as universally preferable. At the same time, cardiac PET has been linked to key benefits that could improve patient care if only more clinicians could use it. ASNC's next president, Andrew Einstein, MD, PhD, discussed this and more in a new interview.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

$37M radiology scam lands doc in prison | Missed f/u rec leads to terminal dx | Engineer guilty of sharing trade secrets
Radiologist FDA leader wants gen-AI regulated like human docs | AI for checking AI's work | Radiation could treat Parkinson's
Sirona Medical raises $40M in financing | Siemens ending general ultrasound sales | Nasdaq threatens radiology vendor | More
Rad Partners pivots in tough lending landscape | Radiologists high on hiring wish lists | Imaging group sells to private equity
Radiopharma partnership targets copper-67 production | Whole-body PET/CT in under 1 minute | BC survivors recommend CEM | More
AI buyer's guide | Adapting AI tools for pediatric patients | AI efficiency gains | The evolving AI regulatory landscape | More
Radiology vendor running out of cash | The high cost of contrast reactions | A new solution to radiopharma delivery challenges
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup